EXETF (Extendicare) Short-Term Debt: $14 Mil (As of Mar. 2026)


EXETF Extendicare Inc EXETF
76 GF Score
Price $25.78
GF Value $9.68
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Extendicare Short-Term Debt?

Extendicare EXETF +5.14% 76 Short-Term Debt is $14 Mil as of Mar. 2026. GuruFocus rates EXETF with a GF Score™ of 76/100 and a GF Value™ of $9.68 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Extendicare's Short-Term Debt for the quarter that ended in Mar. 2026 was $14 Mil.

Extendicare's quarterly Short-Term Debt declined from Sep. 2025 ($15 Mil) to Dec. 2025 ($14 Mil) and declined from Dec. 2025 ($14 Mil) to Mar. 2026 ($14 Mil).

Extendicare's annual Short-Term Debt increased from Dec. 2023 ($15 Mil) to Dec. 2024 ($22 Mil) but then declined from Dec. 2024 ($22 Mil) to Dec. 2025 ($14 Mil).

Extendicare Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Extendicare Short-Term Debt Related Terms

Extendicare Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Extendicare's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Extendicare Short-Term Debt Chart

Extendicare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.48 14.16 14.82 21.82 14.39

Extendicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.51 12.34 14.68 14.39 14.24
EXETF
76GF Score
Extendicare Inc EXETF
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $14 Mil mean?
Extendicare (EXETF) has a Short-Term Debt of $14 Mil as of Mar. 2026.
Is Extendicare's Short-Term Debt too high?
Extendicare's current Short-Term Debt is $14 Mil. Overall, Extendicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Short-Term Debt compare to HCA and THC?
Extendicare's Short-Term Debt of $14 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Extendicare's current Short-Term Debt is $14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.68, compared to a current price of $25.78 — trading 166.3% above its estimated fair value. The current Short-Term Debt is $14 Mil. Extendicare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Extendicare (EXETF), the current Short-Term Debt is $14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Extendicare (EXETF) Overvalued in 2026?

Based on GuruFocus' analysis, Extendicare stock appears to be overvalued. The current stock price of $25.78 is trading 166.3% above its estimated GF Value™ of $9.68. GuruFocus considers Extendicare to be Significantly Overvalued.

Key valuation signals for EXETF:

  • Short-Term Debt: $14 Mil
  • GF Value™: $9.68 vs. price of $25.78 (166.3% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Extendicare Business Description

Address 3000 Steeles Avenue East, Suite 400, Markham, ON, CAN, L3R 4T9
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
76GF Score

Get the complete analysis for EXETF

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.78
Price
$9.68
GF Value